NCT03229278
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +73 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
Clinical trial condition
Stage III Bladder Cancer
Explore clinical trials studying Stage III Bladder Cancer. Study availability and eligibility vary by location and protocol.
14 public trials
0 recruiting studies
Stage III Bladder Cancer trial results
NCT05025748
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +68 more
- Locations
-
- Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States
- Karmanos Cancer Institute at McLaren Clarkston Clarkston, Michigan, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Karmanos Cancer Institute at McLaren Flint Flint, Michigan, United States
NCT00478361
- Conditions
- Distal Urethral Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +21 more
- Locations
-
- Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield Springfield, Missouri, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT01846520
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +137 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Completed
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
NCT02646319
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced Malignant Neoplasm, +73 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT00112671
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +15 more
- Locations
-
- Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada
NCT00666562
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Lahey Hospital and Medical Center Burlington, Massachusetts, United States
- Minneapolis Veterans Medical Center Minneapolis, Minnesota, United States
- University of Rochester Rochester, New York, United States
Completed
Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer
NCT01938573
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +12 more
- Locations
-
- VA Puget Sound Health Care System Seattle, Washington, United States
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00028756
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
- Locations
-
Not specified
NCT00407485
- Conditions
- Adenocarcinoma of the Bladder, Distal Urethral Cancer, Female Urogenital Diseases, +23 more
- Locations
-
- City of Hope Duarte, California, United States